Member Info for daft63

It don't get any more obvious.

The fact we stayed green was a good omen, look at the volume, much of that was traders doing a 4x, in, out, in and out. The £1 mark was a trigger point, and for the traders a dump point. But as exposure increases so will the stickier hands who see further than 4pm, a test success will create much interest from bigger players and the grip will tighten, the trading float will reduce causing less swing, more stability, but the traders are good for raising both the SP and awareness and so a necessary evil, so to speak. The traders will do well here, but the long term holders should ignore the noise and focus on facts, knowing that they hold a desirable product. Be sure that approaches will be made upon successful delivery of a fit for purpose testing system and that this time spent now is forging longer term gains. Be patient and deaf to the jokers and clowns antics, at £30m Mcap the games are just starting.atb.

Trigger point for some, start point for others. This could still 10 bag from here, at £37m we are at a fraction of others, and if Prof Carl delivers then this price will be looked back at as a missed chance. Gla

Sorry I meant £2 +, not 2p+.

Can we move away from the idea that TB selling RMS shares was bad, he got 7.5 times their face value of 0.4p, and then used that cash to fund the Paraytec venture to date, and give a huge dividend to shareholders, it was exactly what we should expect from an Aim CEO, or are you so used to them shafting the shareholders and frittering the cash on jaunts and jollies that you can't understand the basics anymore. Those here who got in because of the dividend are sitting on circa 10pmax BRH shares if they held out, many who are lth's are in profit or a free ride, and DCT have just done the same thing here but we don't moan about it, just respect they have made money and moved on like we will in time. Its all relative , some will sell today whilst others will see potential next week at 2p+ and buy, and if you don't like how it works then just don't participate, but if you think it clever to **** off a CEO who dispenses 80% divis then perhaps you need help! Atb.

Just filling in that lunch gap 63-65. Sellers should be aware that in 3 weeks any number could be in front of 65p but 0.

Our MCap is £14m, it does not matter about competition, billions of tests will be required globally, no one can provide them all. Our test will appeal because of its ease of use and multifunctionality, across a broad spectrum of diagnosis requirements, and if the cancer detection part of the test gets proved up, then imagine its ability to ease the pressure on the health provision industry. We only need a slice of the cake not the whole bloody bakery.

5 Feb
This place is stunning under the night sky!
@SheffieldMBB
Carl “Fast,Sensitive Covid-19 Test” Smythe
@carlsmythe
@SheffieldMBB
If you squint, you can just make me out putting the finishing touches to BMS379
1:46 pm · 6 Feb 2021·Twitter

There is no need for an RNS, as Phasefocus is not a publicly traded company, updates are usually in the form of periodic reports or specific progress updates.

We own 42.8% of Phasefocus, refer to Half Year Report RNS03/12/2020..

Just for info. In early 2020 DCT owned 8.5%, which was approx 3m shares, and that had not cost them more than £500k. In early May during a spike they offloaded about 400k share for roughly £150K, and in Aug 2020 another 400k shares at 20p is giving them another £80K. They did this sale just before a 70p spike showing no inside knowledge at all, but they still carried 6.5% /2m+ shares into the dividend getting them a cool £850K. Since Jan 18th they have sold at least another 1m of their holding in the High 30ps or low 40s so another £400K. Do the maths, it worked for them.

The scientists have achieved incredible results in getting vaccines to market in the short time, but much is still unknown, immunity duration is not really expected to be more than 6 months, and may be much less in older generations,now with 7.8billion population requiring 2 jabs every 6 months minimum, I suspect that its not realistic at present to anticipate an end to relentless testing. Indeed if the global economy is to have expectations of any easing at all, then expect billions of tests annually. And as the virus mutates and becomes stronger and more effective at transmission expect more countries to impose quarantine rather than isolation, which will result in guess what, more testing. Braveheart don't need to be the only game in town, then just need a slice of the pie. And sorry to be pessimistic but this is not the beginning of the end, it might not even be the end of the beginning, nobody knows where or how or what the virus brings next. Have a great weekend folks.

www.forbes.com › sites › 2020/12/22
The Moderna Vaccine's Antibodies May Not Last As Long As We Hoped - Forbes

https://www.scotsman.com/health/how-long-does-covid-vaccine-last-how-long-antibodies-provide-protection-and-why-you-may-need-more-vaccinations-3100946

That was published 8 hours ago, it really is a fast moving world, and dont believe that it won't carry on evolving and mutating, its very structure is to react to changes and become more effective at survival, testing is here for a long time perhaps even forever.

https://www.washingtonpost.com/health/2021/01/28/covid-vaccine-variant-south-africa/

The Washington Post
Novavax vaccine protects against coronavirus in variant hot spots but proved less effective against strain in South Africa
8 hours ago

I've done this post already but its worth a reminder.

In 2018 there were 1,400,000,000 International travellers!

I think any drop will get bought into, in just 4 weeks this is a goer, only 25m freefloat, with such a low Mcap. We will see but I anticipate people gaining confidence from knowing its not a duster, so to speak, and with so few shares even a small uptake would lift. How many holders are gripping tight or going to gamble on a cheaper buyback, that's the question.

It looks like a 93 sec test then!